Zaloguj się
dr hab. Danuta Jantas
dr hab. Danuta Jantas
+48 12 3343721
jantas@if-pan.krakow.pl
pokój 2.1 
Department of Brain BiochemistryDokonania naukowe
- Publikacje
Neuroprotective effects of the allosteric agonist of metabotropic glutamate receptor 7 AMN082 on oxygen-glucose deprivation- and kainate-induced neuronal cell death
Autorzy: Domin, H., Jantas, D., ͆miałowska, M.
DOI: 10.1016/j.neuint.2014.12.010
Date: 2015-01-01
The role of ATM kinase in neurodegeneration,Znaczenie kinazy ATM w procesach neurodegeneracyjnych
Autorzy: Chwastek, J., Jantas, D., Lasoń, W.
DOI:
Date: 2014-01-01
Neuroprotective effects of metabotropic glutamate receptor group II and III activators against MPP(+)-induced cell death in human neuroblastoma SH-SY5Y cells: The impact of cell differentiation state
Autorzy: Jantas, D., Greda, A., Golda, S., Korostynski, M., Grygier, B., Roman, A., Pilc, A., Lason, W.
DOI: 10.1016/j.neuropharm.2014.03.019
Date: 2014-01-01
Group III mGlu receptor agonist, ACPT-I, exerts potential neuroprotective effects in vitro and in vivo
Autorzy: Domin, H., Gołembiowska, K., Jantas, D., Kamińska, K., Ziȩba, B., Śmiałowska, M.
DOI: 10.1007/s12640-013-9455-7
Date: 2014-01-01
The predominant protective effect of tianeptine over other antidepressants in models of neuronal apoptosis: The effect blocked by inhibitors of MAPK/ERK1/2 and PI3-K/Akt pathways
Autorzy: Jantas, D., Krawczyk, S., Lason, W.
DOI: 10.1007/s12640-013-9430-3
Date: 2014-01-01
Lack of neuroprotective effect of celastrol under conditions of proteasome inhibition by lactacystin in in vitro and in vivo studies: Implications for Parkinson's disease
Autorzy: Konieczny, J., Jantas, D., Lenda, T., Domin, H., Czarnecka, A., Kuter, K., Śmiałowska, M., Lasoń, W., Lorenc-Koci, E.
DOI: 10.1007/s12640-014-9477-9
Date: 2014-01-01
Emulsion-core and polyelectrolyte-shell nanocapsules: Biocompatibility and neuroprotection against SH-SY5Y cells
Autorzy: Piotrowski, M., Szczepanowicz, K., Jantas, D., Leśkiewicz, M., Lasoń, W., Warszyński, P.
DOI: 10.1007/s11051-013-2035-1
Date: 2013-01-01
The extent of neurodegeneration and neuroprotection in two chemical in vitro models related to parkinson's disease is critically dependent on cell culture conditions
Autorzy: Jantas, D., Roman, A., Kuśmierczyk, J., Lorenc-Koci, E., Konieczny, J., Lenda, T., Lasoń, W.
DOI: 10.1007/s12640-012-9374-z
Date: 2013-01-01
Antidepressants attenuate the dexamethasone-induced decrease in viability and proliferation of human neuroblastoma SH-SY5Y cells: A involvement of extracellular regulated kinase (ERK1/2)
Autorzy: Leskiewicz, M., Jantas, D., Regulska, M., Kaczanowska, J., Basta-Kaim, A., Budziszewska, B., Kubera, M., Lason, W.
DOI: 10.1016/j.neuint.2013.07.007
Date: 2013-01-01
Neuroprotective effects of MAPK/ERK1/2 and calpain inhibitors on lactacystin-induced cell damage in primary cortical neurons
Autorzy: Jantas, D., Lorenc-Koci, E., Kubera, M., Lason, W.
DOI: 10.1016/j.neuro.2011.05.013
Date: 2011-01-01
